Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation
- 1 July 2000
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 109 (1), 27-32
- https://doi.org/10.1016/s0002-9343(00)00396-x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: A double blind randomized trialJournal of Laboratory and Clinical Medicine, 1998
- A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patientsAmerican Journal of Kidney Diseases, 1998
- Iron deficiency anemiaPostgraduate Medicine, 1996
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Effect of intravenous iron dextran on rheumatoid synovitis.Annals Of The Rheumatic Diseases, 1985
- Lymph node enlargement after a single massive infusion of iron dextranJournal of Clinical Pathology, 1968
- TOTAL-DOSE IRON-DEXTRAN INFUSIONS IN GENERAL SURGERYThe Lancet, 1967
- Anaemia in obstetrics: an evaluation of treatment by iron-dextran infusion.BMJ, 1965
- Valency Investigations of Iron Dextran (‘Imferon’)Nature, 1965
- Reactions to Total Dose Intravenous Infusion of Iron Dextran (Imferon)BMJ, 1965